A recent study has found a significant link between cannabis use and an increased risk of serious cardiovascular events. As cannabis legalization expands in Europe and North America, awareness of its health implications becomes increasingly important. The systematic review and meta-analysis analyzed data from 24 studies involving over 432 million patients and uncovered concerning trends regarding heart health.
Key findings include: – A 29% higher risk of acute coronary syndrome (risk ratio of 1.29) – A 20% increased risk of stroke (risk ratio of 1.20) – More than double the risk of cardiovascular death (risk ratio of 2.10)
These major adverse cardiovascular events (MACE) include non-fatal heart attacks, strokes, and deaths from heart-related causes.
Researchers investigated several biological mechanisms that could explain these findings. Cannabinoids, such as THC and CBD, interact with CB1 and CB2 receptors, influencing the cardiovascular system. Activation of the CB1 receptor has been linked to oxidative stress, inflammation, and vascular dysfunction. The study notes that this activation can cause tissue injury, cell death, and contribute to conditions that promote heart disease.
The study also highlights the rise in high-potency cannabis products, which have become more prevalent over the last decade. These products, often with elevated THC levels, may exacerbate cardiovascular risks by causing blood vessels to constrict, thereby increasing the heart’s oxygen demand and potentially triggering ischemia.
Demographic factors like age and gender play a role in the observed risks. Notably, young adults aged 18 to 36 face a significantly higher risk of acute coronary syndrome, with an odds ratio of 5.24. Furthermore, a 2024 UK Biobank analysis indicated that heavy cannabis use is associated with increased cardiovascular mortality in women, but not in men. This gender disparity emphasizes the need for further specialized research.
While the review considered data from both medical and recreational cannabis users, only one included study focused solely on medical cannabis. The authors stress the importance of these findings for public awareness and clinical practice. They recommend that healthcare providers routinely inquire about patients’ cannabis usage during evaluations for serious cardiovascular symptoms, noting that many users may not disclose their habits or may be self-medicating without supervision.
The authors of the study call for better data collection regarding cannabis use in the context of cardiovascular health. They recommend: 1. Including cannabis use in cardiovascular patient assessments. 2. Raising public awareness about the cardiovascular risks associated with cannabis. 3. Conducting more targeted research based on age and gender.
As cannabis consumption continues to grow globally, understanding the nuances of its health effects becomes more urgent. Future research should examine how variables such as dosage, method of consumption, and cannabinoid profiles might influence the associated risks. Until more is known, caution is advised in the context of cannabis use and heart health.
German 
English 
Spanish 
Czech